tiprankstipranks
Advertisement
Advertisement

ABSI Stock Latest News

Absci price target raised to $15 from $13 at BTIG
The FlyAbsci price target raised to $15 from $13 at BTIG
59m ago
ABSI
Absci reports Q2 EPS (21c), consensus (20c)
PremiumThe Fly
Absci reports Q2 EPS (21c), consensus (20c)
22d ago
ABSI
Closing Bell Movers: CoreWeave spikes 17% on results and outlook
PremiumThe Fly
Closing Bell Movers: CoreWeave spikes 17% on results and outlook
22d ago
HRB
SVV
Analyst Reiterates Buy on ABSI, Sees Upside Ahead of ABS-201 Readout with ATLAS AI Platform Support and Unchanged $16 Price Target
PremiumRatings
Analyst Reiterates Buy on ABSI, Sees Upside Ahead of ABS-201 Readout with ATLAS AI Platform Support and Unchanged $16 Price Target
27d ago
ABSI
AbSci: Buy Rating Reaffirmed as ABS-201 Hair-Loss Program Advances; $11 Price Target Maintained
PremiumRatings
AbSci: Buy Rating Reaffirmed as ABS-201 Hair-Loss Program Advances; $11 Price Target Maintained
27d ago
ABSI
Absci: Buy Rating Backed by Promising ABS-201 Early Data and Strengthened Cash Runway to 2028
PremiumRatingsAbsci: Buy Rating Backed by Promising ABS-201 Early Data and Strengthened Cash Runway to 2028
27d ago
ABSI
Absci Corp. Earnings Call Highlights ABS-201 And Cash
Premium
Company Announcements
Absci Corp. Earnings Call Highlights ABS-201 And Cash
27d ago
ABSI
Absci Highlights Positive Phase 1 Data and Financing
Premium
Company Announcements
Absci Highlights Positive Phase 1 Data and Financing
28d ago
8K
ABSI
ABSI Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
ABSI Upcoming Earnings Report: What to Expect?
1M ago
ABSI
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged
PremiumRatings
Absci Maintained at Buy as Yazdi Highlights ABS-201’s Dual Alopecia and Endometriosis Upside; $13 Price Target Unchanged
1M ago
ABSI
Absci management to meet virtually with KeyBanc
PremiumThe Fly
Absci management to meet virtually with KeyBanc
2M ago
ABSI
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
PremiumWeekend Updates
ASE, ProQR, AbSci, Ultragenyx, YPF: Insider Turmoil
2M ago
ASX
YPF
Absci director buys $149K in common stock
PremiumThe FlyAbsci director buys $149K in common stock
2M ago
ABSI
AbSci: Buy Rating Backed by Proprietary Wet‑Lab Data Moat and Emerging Validation of AI‑Enabled Biologic Design
Premium
Ratings
AbSci: Buy Rating Backed by Proprietary Wet‑Lab Data Moat and Emerging Validation of AI‑Enabled Biologic Design
2M ago
ABSI
Absci price target raised to $10 from $4.10 at Morgan Stanley
Premium
The Fly
Absci price target raised to $10 from $4.10 at Morgan Stanley
3M ago
ABSI
Absci: Clean Phase 1 Data, Strengthened ABS-201 Outlook Drive Price Target Increase from $9 to $13 and Buy Rating
PremiumRatings
Absci: Clean Phase 1 Data, Strengthened ABS-201 Outlook Drive Price Target Increase from $9 to $13 and Buy Rating
3M ago
ABSI
Absci price target raised to $16 from $8 at H.C. Wainwright
PremiumThe Fly
Absci price target raised to $16 from $8 at H.C. Wainwright
3M ago
ABSI
Absci Announces $100 Million Public Equity Offering
PremiumCompany Announcements
Absci Announces $100 Million Public Equity Offering
3M ago
8K
ABSI
Midday Fly By: Alphabet to replace Verizon in Dow blue-chip index
PremiumThe Fly
Midday Fly By: Alphabet to replace Verizon in Dow blue-chip index
3M ago
BB
BP
Absci Reports Positive Phase 1 Data for ABS-201
PremiumCompany AnnouncementsAbsci Reports Positive Phase 1 Data for ABS-201
3M ago
8K
ABSI
Absci prices 13.5M shares at $7.41 in public offering
Premium
The Fly
Absci prices 13.5M shares at $7.41 in public offering
3M ago
ABSI
Absci reports Phase 1 data from human trial of ABS-201
Premium
The Fly
Absci reports Phase 1 data from human trial of ABS-201
3M ago
ABSI

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >